Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 244

1.

Cigarette smoking and the risk of supraventricular and ventricular tachyarrhythmias in high-risk cardiac patients with implantable cardioverter defibrillators.

Goldenberg I, Moss AJ, McNitt S, Zareba W, Daubert JP, Hall WJ, Andrews ML; Multicenter Automatic Defibrillator Implantation Trial-II Investigators.

J Cardiovasc Electrophysiol. 2006 Sep;17(9):931-6. Epub 2006 Jun 6.

PMID:
16759297
2.

Persistent atrial fibrillation is associated with appropriate shocks and heart failure in patients with left ventricular dysfunction treated with an implantable cardioverter defibrillator.

Rienstra M, Smit MD, Nieuwland W, Tan ES, Wiesfeld AC, Anthonio RL, Van den Berg MP, Van Veldhuisen DJ, Van Gelder IC.

Am Heart J. 2007 Jan;153(1):120-6.

PMID:
17174649
3.

Factors influencing appropriate firing of the implanted defibrillator for ventricular tachycardia/fibrillation: findings from the Multicenter Automatic Defibrillator Implantation Trial II (MADIT-II).

Singh JP, Hall WJ, McNitt S, Wang H, Daubert JP, Zareba W, Ruskin JN, Moss AJ; MADIT-II Investigators.

J Am Coll Cardiol. 2005 Nov 1;46(9):1712-20. Epub 2005 Oct 10.

4.

Predictors of appropriate implantable cardioverter-defibrillator therapy during long-term follow-up of patients with coronary artery disease.

Blumer J, Wolber T, Hellermann J, Holzmeister J, Binggeli C, Duru F, Brunckhorst C.

Int Heart J. 2009 May;50(3):313-21.

5.

Obesity as a risk factor for sustained ventricular tachyarrhythmias in MADIT II patients.

Pietrasik G, Goldenberg I, McNitt S, Moss AJ, Zareba W.

J Cardiovasc Electrophysiol. 2007 Feb;18(2):181-4.

PMID:
17338766
6.

The World Trade Center attack: increased frequency of defibrillator shocks for ventricular arrhythmias in patients living remotely from New York City.

Shedd OL, Sears SF Jr, Harvill JL, Arshad A, Conti JB, Steinberg JS, Curtis AB.

J Am Coll Cardiol. 2004 Sep 15;44(6):1265-7.

7.

Long-term clinical course of patients after termination of ventricular tachyarrhythmia by an implanted defibrillator.

Moss AJ, Greenberg H, Case RB, Zareba W, Hall WJ, Brown MW, Daubert JP, McNitt S, Andrews ML, Elkin AD; Multicenter Automatic Defibrillator Implantation Trial-II (MADIT-II) Research Group.

Circulation. 2004 Dec 21;110(25):3760-5. Epub 2004 Dec 6.

8.

High incidence of appropriate and inappropriate ICD therapies in children and adolescents with implantable cardioverter defibrillator.

Korte T, Köditz H, Niehaus M, Paul T, Tebbenjohanns J.

Pacing Clin Electrophysiol. 2004 Jul;27(7):924-32.

PMID:
15271011
9.

Implantable cardioverter-defibrillators in patients with left ventricular noncompaction.

Kobza R, Jenni R, Erne P, Oechslin E, Duru F.

Pacing Clin Electrophysiol. 2008 Apr;31(4):461-7. doi: 10.1111/j.1540-8159.2008.01015.x.

PMID:
18373765
10.

Implantable cardioverter-defibrillator shocks in patients with a left ventricular assist device.

Ambardekar AV, Allen LA, Lindenfeld J, Lowery CM, Cannon AP, Cleveland JC Jr, Brieke A, Sauer WH.

J Heart Lung Transplant. 2010 Jul;29(7):771-6. doi: 10.1016/j.healun.2010.02.001. Epub 2010 Mar 29.

PMID:
20347337
11.

Time dependence of defibrillator benefit after coronary revascularization in the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II.

Goldenberg I, Moss AJ, McNitt S, Zareba W, Hall WJ, Andrews ML, Wilber DJ, Klein HU; MADIT-II Investigators.

J Am Coll Cardiol. 2006 May 2;47(9):1811-7. Epub 2006 Apr 17.

12.

QT interval variability and spontaneous ventricular tachycardia or fibrillation in the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II patients.

Haigney MC, Zareba W, Gentlesk PJ, Goldstein RE, Illovsky M, McNitt S, Andrews ML, Moss AJ; Multicenter Automatic Defibrillator Implantation Trial II investigators.

J Am Coll Cardiol. 2004 Oct 6;44(7):1481-7.

13.

[The implantable cardioverter-defibrillator and hypertrophic cardiomyopathy. Experience at three centers].

Marín F, Gimeno JR, Payá E, García-Alberola A, Pérez-Alvarez L, Fernández X, de la Morena G, Sogorb F, Castro-Beiras A, Valdés M, Martínez JG, Monserrat L.

Rev Esp Cardiol. 2006 Jun;59(6):537-44. Spanish.

14.

Implantable cardioverter-defibrillator efficacy in patients with heart failure and left ventricular dysfunction (from the MADIT II population).

Zareba W, Piotrowicz K, McNitt S, Moss AJ; MADIT II Investigators.

Am J Cardiol. 2005 Jun 15;95(12):1487-91.

PMID:
15950580
15.

Smoking is associated with an increased risk of first and recurrent ventricular tachyarrhythmias in ischemic and nonischemic patients with mild heart failure: a MADIT-CRT substudy.

Plank B, Kutyifa V, Moss AJ, Huang DT, Ruwald AC, McNitt S, Polonsky B, Zareba W, Goldenberg I, Aktas MK.

Heart Rhythm. 2014 May;11(5):822-7. doi: 10.1016/j.hrthm.2014.02.007. Epub 2014 Feb 6.

PMID:
24509214
16.

Implantable cardioverter defibrillator events in patients with asymptomatic nonsustained ventricular tachycardia: is device implantation justified?

Russo AM, Nayak H, Verdino R, Springman J, Gerstenfeld E, Hsia H, Marchlinski FE.

Pacing Clin Electrophysiol. 2003 Dec;26(12):2289-95.

PMID:
14675014
17.

Outcome of women versus men with ventricular tachyarrhythmias treated with the implantable cardioverter defibrillator.

Pires LA, Sethuraman B, Guduguntla VD, Todd KM, Yamasaki H, Ravi S.

J Cardiovasc Electrophysiol. 2002 Jun;13(6):563-8.

PMID:
12108497
18.

Are implantable cardioverter defibrillator shocks a surrogate for sudden cardiac death in patients with nonischemic cardiomyopathy?

Ellenbogen KA, Levine JH, Berger RD, Daubert JP, Winters SL, Greenstein E, Shalaby A, Schaechter A, Subacius H, Kadish A; Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE) Investigators.

Circulation. 2006 Feb 14;113(6):776-82. Epub 2006 Feb 6.

19.

Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact.

Daubert JP, Zareba W, Cannom DS, McNitt S, Rosero SZ, Wang P, Schuger C, Steinberg JS, Higgins SL, Wilber DJ, Klein H, Andrews ML, Hall WJ, Moss AJ; MADIT II Investigators.

J Am Coll Cardiol. 2008 Apr 8;51(14):1357-65. doi: 10.1016/j.jacc.2007.09.073.

20.

Clinical course and implantable cardioverter defibrillator therapy in postinfarction women with severe left ventricular dysfunction.

Zareba W, Moss AJ, Jackson Hall W, Wilber DJ, Ruskin JN, McNitt S, Brown M, Wang H; MADIT II Investigators.

J Cardiovasc Electrophysiol. 2005 Dec;16(12):1265-70.

PMID:
16403053

Supplemental Content

Support Center